IL10 and Behcet disease: Further analysis of the treatment regimen with the normalised saliva data revealed that salivary concentrations of IL-10 (p=0.03) and IL-12p70 (p=0.03) were significantly lower in patients taking both COLC and AZA than BD patients treated with only AZA.